在直肠癌中抗辐射:纳米颗粒能否扭转局面?
Diogo Coelho1,2,3, Diogo Estêvão1,2,4,5, Maria José Oliveira1,2,5
1i3S - Instituto de Investigação e Inovação em Saúde, Universidade Do Porto, Rua Alfredo Allen 208, Porto, 4200‑135, Portugal.
Molecular cancer
|January 30, 2025
概括
直肠癌与结肠癌不同,通常表现出放射电阻. 纳米药物在改善直肠癌患者的新辅助疗法响应率方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 纳米医学是一种纳米医学.
背景情况:
- 结肠直肠癌占全球结肠直肠癌的35%以上,与结肠癌相比,其具有独特的分子和解剖特征.
- 新辅助化学放射治疗对于局部发达的直肠癌至关重要,但放射电阻经常导致不良结果.
- 了解这些差异是制定更有效的治疗策略的关键.
研究的目的:
- 为了阐明直肠和结肠瘤之间的分子区别.
- 探索直肠癌中放射电阻背后的机制.
- 审查有希望的纳米药物,以增强新辅助疗法反应.
主要方法:
- 关于直肠癌和结肠癌之间的分子差异的文献综述.
- 对研究直肠癌放射电阻的研究进行分析.
- 在直肠癌治疗中纳米医学应用的调查.
主要成果:
- 直肠和结肠癌表现出显著的分子变异,影响治疗方法.
- 直肠癌中的放射电阻是一种复杂的现象,与预后不佳有关.
- 各种纳米药物显示出改善放射治疗疗效和药物输送的潜力.
结论:
- 准分子差异和克服放射电阻对于推进直肠癌治疗至关重要.
- 纳米医学提供了一种可行的策略,以提高新辅助化学或放射治疗的有效性.
- 对有针对性的纳米药物输送的进一步研究可以改善患者的治疗结果.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...